stella
beta
Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma — Stella
Recruiting
Back to Hepato Cellular Carcinoma (HCC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
Switzerland
University Hospital Basel, Basel
Hôpitaux Universitaires de Genève, Geneva
Kantonsspital St. Gallen, Sankt Gallen
View full record on ClinicalTrials.gov